Page last updated: 2024-11-05

5-hydroxyindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

5-Hydroxyindole, also known as 5-hydroxytryptamine (5-HT), is a neurotransmitter that plays a critical role in mood regulation, sleep, appetite, and cognition. It is synthesized from the amino acid tryptophan through a series of enzymatic reactions in the body. 5-HT is involved in a wide range of physiological and psychological processes, including: 1) regulating mood and emotions: Low levels of 5-HT are linked to depression and anxiety, while high levels are associated with feelings of happiness and well-being. 2) regulating sleep-wake cycles: 5-HT helps to regulate the circadian rhythm, which controls our sleep-wake patterns. 3) regulating appetite: 5-HT plays a role in suppressing appetite and promoting feelings of satiety. 4) regulating cognition: 5-HT is involved in learning, memory, and attention. 5-HT is the target of many psychoactive drugs, including antidepressants, anti-anxiety medications, and hallucinogens. Research into 5-HT is ongoing, with a focus on understanding its role in various neurological and psychiatric disorders, such as depression, anxiety, schizophrenia, and autism.'

Cross-References

ID SourceID
PubMed CID16054
CHEMBL ID404923
CHEBI ID89649
SCHEMBL ID50566
MeSH IDM0087621

Synonyms (67)

Synonym
gtpl2295
NCIOPEN2_001272
brn 0112349
hydroxy-5 indole [french]
ccris 4422
nsc 87503
einecs 217-782-6
MLS000039632
smr000037055
indol-5-ol
wln: t56 bmj gq
5-hydroxy-1h-indole
1953-54-4
5-hydroxyindole ,
hydroxy-5 indole
1h-indol-5-ol
nsc87503
nsc-87503
5-hydroxyindole, 97%
5-hi
H-6044
H-6048
AC-5464
5h1 ,
KUC106613N
ksc-09-215b
chebi:89649 ,
CHEMBL404923
FT-0653849
H0252
EN300-79057
5-hydroxy-indole
320un7xzyn ,
hydroxy-5 indole [french]
unii-320un7xzyn
5-21-03-00018 (beilstein handbook reference)
STK580144
AKOS005206937
HMS2188A10
FT-0601202
AM20030268
AB00494
4B3C
SCHEMBL50566
5hydroxy-1h-indole
5-hydroxy-indol
5-hydroxy indole
1-h-indol-5-ol
5-hydroxylindole
3FUH
PS-3277
cid_16054
bdbm32212
(r)-(+)-7-methoxy2-aminotetralin
h-115 ,
mfcd00005677
DTXSID00173187
CS-W001160
SY008069
Q27073984
BCP27601
BBL036782
1h-indol-5-ol.
1h-indole-5-ol
HY-W001160
Z1203162319
PD050590
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxyindolesAny member of the class of indoles carrying at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (35)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
15-lipoxygenase, partialHomo sapiens (human)Potency10.00000.012610.691788.5700AID887
ATAD5 protein, partialHomo sapiens (human)Potency4.46680.004110.890331.5287AID504467
TDP1 proteinHomo sapiens (human)Potency16.36010.000811.382244.6684AID686978
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency14.12540.036619.637650.1187AID2100
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency7.94330.65619.452025.1189AID927
gemininHomo sapiens (human)Potency8.19950.004611.374133.4983AID624297
neuropeptide S receptor isoform AHomo sapiens (human)Potency5.01190.015812.3113615.5000AID1461
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)Potency7.94331.584913.004325.1189AID927
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)2,000.0000212.00001,235.33332,000.0000AID977608
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)IC50 (µMol)50.00000.17369.803229.2701AID712
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)IC50 (µMol)50.00000.17369.803229.2701AID712
Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)1,500.00000.00051.28547.6500AID420374; AID420375
TyrosinaseMus musculus (house mouse)IC50 (µMol)68.00000.03002.21045.2300AID428332
large T antigenBetapolyomavirus macacaeIC50 (µMol)80.22000.160024.9724100.0000AID1903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)EC50 (µMol)1,000.00000.12802.80188.9000AID321284
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1E1Homo sapiens (human)Km575.00001.60004.63676.4000AID1639874
Sulfotransferase 1A1Homo sapiens (human)Km6.62000.17001.83436.6200AID1639868
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (118)

Processvia Protein(s)Taxonomy
proteolysisLeukotriene A-4 hydrolaseHomo sapiens (human)
lipid metabolic processLeukotriene A-4 hydrolaseHomo sapiens (human)
response to zinc ionLeukotriene A-4 hydrolaseHomo sapiens (human)
leukotriene biosynthetic processLeukotriene A-4 hydrolaseHomo sapiens (human)
protein metabolic processLeukotriene A-4 hydrolaseHomo sapiens (human)
peptide catabolic processLeukotriene A-4 hydrolaseHomo sapiens (human)
response to peptide hormoneLeukotriene A-4 hydrolaseHomo sapiens (human)
type I pneumocyte differentiationLeukotriene A-4 hydrolaseHomo sapiens (human)
negative regulation of tumor necrosis factor productionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of protein phosphorylationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
intracellular calcium ion homeostasisNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
learning or memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
short-term memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of cell population proliferationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
negative regulation of tumor necrosis factor productionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of MAPK cascadeNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of angiogenesisNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synapse organizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
sensory processingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of protein metabolic processNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
dendritic spine organizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
modulation of excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
dendrite arborizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of long-term synaptic potentiationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of amyloid-beta formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
negative regulation of amyloid-beta formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of amyloid precursor protein catabolic processNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to amyloid-betaNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of amyloid fibril formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of CoA-transferase activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
sulfationSulfotransferase 1E1Homo sapiens (human)
ethanol catabolic processSulfotransferase 1E1Homo sapiens (human)
estrogen catabolic processSulfotransferase 1E1Homo sapiens (human)
steroid metabolic processSulfotransferase 1E1Homo sapiens (human)
estrogen metabolic processSulfotransferase 1E1Homo sapiens (human)
positive regulation of fat cell differentiationSulfotransferase 1E1Homo sapiens (human)
3'-phosphoadenosine 5'-phosphosulfate metabolic processSulfotransferase 1E1Homo sapiens (human)
sulfationSulfotransferase 1E1Homo sapiens (human)
sulfationSulfotransferase 1A1Homo sapiens (human)
ethanol catabolic processSulfotransferase 1A1Homo sapiens (human)
catecholamine metabolic processSulfotransferase 1A1Homo sapiens (human)
xenobiotic metabolic processSulfotransferase 1A1Homo sapiens (human)
estrogen metabolic processSulfotransferase 1A1Homo sapiens (human)
amine metabolic processSulfotransferase 1A1Homo sapiens (human)
flavonoid metabolic processSulfotransferase 1A1Homo sapiens (human)
3'-phosphoadenosine 5'-phosphosulfate metabolic processSulfotransferase 1A1Homo sapiens (human)
sulfationSulfotransferase 1A1Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
double-strand break repair via homologous recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
telomere maintenance via recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
double-strand break repair via homologous recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA recombinase assemblyDNA repair protein RAD51 homolog 1Homo sapiens (human)
regulation of protein phosphorylationDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA unwinding involved in DNA replicationDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA repairDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA damage responseDNA repair protein RAD51 homolog 1Homo sapiens (human)
regulation of double-strand break repair via homologous recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
telomere maintenance via telomere lengtheningDNA repair protein RAD51 homolog 1Homo sapiens (human)
replication fork processingDNA repair protein RAD51 homolog 1Homo sapiens (human)
interstrand cross-link repairDNA repair protein RAD51 homolog 1Homo sapiens (human)
positive regulation of DNA ligationDNA repair protein RAD51 homolog 1Homo sapiens (human)
meiotic cell cycleDNA repair protein RAD51 homolog 1Homo sapiens (human)
cellular response to ionizing radiationDNA repair protein RAD51 homolog 1Homo sapiens (human)
cellular response to hydroxyureaDNA repair protein RAD51 homolog 1Homo sapiens (human)
cellular response to camptothecinDNA repair protein RAD51 homolog 1Homo sapiens (human)
replication-born double-strand break repair via sister chromatid exchangeDNA repair protein RAD51 homolog 1Homo sapiens (human)
mitotic recombination-dependent replication fork processingDNA repair protein RAD51 homolog 1Homo sapiens (human)
double-strand break repair involved in meiotic recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
regulation of DNA damage checkpointDNA repair protein RAD51 homolog 1Homo sapiens (human)
chromosome organization involved in meiotic cell cycleDNA repair protein RAD51 homolog 1Homo sapiens (human)
reciprocal meiotic recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
mitotic recombinationDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA strand invasionDNA repair protein RAD51 homolog 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (49)

Processvia Protein(s)Taxonomy
RNA bindingLeukotriene A-4 hydrolaseHomo sapiens (human)
aminopeptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
epoxide hydrolase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
leukotriene-A4 hydrolase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
protein bindingLeukotriene A-4 hydrolaseHomo sapiens (human)
peptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
zinc ion bindingLeukotriene A-4 hydrolaseHomo sapiens (human)
tripeptide aminopeptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
metalloaminopeptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
amyloid-beta bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
toxic substance bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
chloride channel regulator activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein homodimerization activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
estrone sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
steroid bindingSulfotransferase 1E1Homo sapiens (human)
protein bindingSulfotransferase 1E1Homo sapiens (human)
sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
flavonol 3-sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
steroid sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
aryl sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
aryl sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
protein bindingSulfotransferase 1A1Homo sapiens (human)
sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
flavonol 3-sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
steroid sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
3'-phosphoadenosine 5'-phosphosulfate bindingSulfotransferase 1A1Homo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
DNA strand exchange activityDNA repair protein RAD51 homolog 1Homo sapiens (human)
chromatin bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
double-stranded DNA bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
single-stranded DNA bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
protein bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
ATP bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
ATP hydrolysis activityDNA repair protein RAD51 homolog 1Homo sapiens (human)
single-stranded DNA helicase activityDNA repair protein RAD51 homolog 1Homo sapiens (human)
enzyme bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
identical protein bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
DNA polymerase bindingDNA repair protein RAD51 homolog 1Homo sapiens (human)
ATP-dependent DNA damage sensor activityDNA repair protein RAD51 homolog 1Homo sapiens (human)
ATP-dependent activity, acting on DNADNA repair protein RAD51 homolog 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (43)

Processvia Protein(s)Taxonomy
extracellular regionLeukotriene A-4 hydrolaseHomo sapiens (human)
nucleoplasmLeukotriene A-4 hydrolaseHomo sapiens (human)
cytosolLeukotriene A-4 hydrolaseHomo sapiens (human)
extracellular exosomeLeukotriene A-4 hydrolaseHomo sapiens (human)
tertiary granule lumenLeukotriene A-4 hydrolaseHomo sapiens (human)
ficolin-1-rich granule lumenLeukotriene A-4 hydrolaseHomo sapiens (human)
cytosolLeukotriene A-4 hydrolaseHomo sapiens (human)
nucleusLeukotriene A-4 hydrolaseHomo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
postsynapseNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
cytosolSulfotransferase 1E1Homo sapiens (human)
nuclear membraneSulfotransferase 1E1Homo sapiens (human)
cytoplasmSulfotransferase 1E1Homo sapiens (human)
cytosolSulfotransferase 1A1Homo sapiens (human)
cytoplasmSulfotransferase 1A1Homo sapiens (human)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
site of double-strand breakDNA repair protein RAD51 homolog 1Homo sapiens (human)
presynaptic intermediate filament cytoskeletonDNA repair protein RAD51 homolog 1Homo sapiens (human)
nuclear ubiquitin ligase complexDNA repair protein RAD51 homolog 1Homo sapiens (human)
nuclear chromosomeDNA repair protein RAD51 homolog 1Homo sapiens (human)
chromosome, telomeric regionDNA repair protein RAD51 homolog 1Homo sapiens (human)
condensed chromosomeDNA repair protein RAD51 homolog 1Homo sapiens (human)
condensed nuclear chromosomeDNA repair protein RAD51 homolog 1Homo sapiens (human)
lateral elementDNA repair protein RAD51 homolog 1Homo sapiens (human)
male germ cell nucleusDNA repair protein RAD51 homolog 1Homo sapiens (human)
nucleusDNA repair protein RAD51 homolog 1Homo sapiens (human)
nucleoplasmDNA repair protein RAD51 homolog 1Homo sapiens (human)
nucleolusDNA repair protein RAD51 homolog 1Homo sapiens (human)
cytoplasmDNA repair protein RAD51 homolog 1Homo sapiens (human)
mitochondrionDNA repair protein RAD51 homolog 1Homo sapiens (human)
mitochondrial matrixDNA repair protein RAD51 homolog 1Homo sapiens (human)
centrosomeDNA repair protein RAD51 homolog 1Homo sapiens (human)
cytosolDNA repair protein RAD51 homolog 1Homo sapiens (human)
PML bodyDNA repair protein RAD51 homolog 1Homo sapiens (human)
site of double-strand breakDNA repair protein RAD51 homolog 1Homo sapiens (human)
perinuclear region of cytoplasmDNA repair protein RAD51 homolog 1Homo sapiens (human)
chromatinDNA repair protein RAD51 homolog 1Homo sapiens (human)
protein-containing complexDNA repair protein RAD51 homolog 1Homo sapiens (human)
condensed nuclear chromosomeDNA repair protein RAD51 homolog 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (34)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1799876Thermal Denaturation Assay from Article 10.1002/cbic.201200521: \\Using a fragment-based approach to target protein-protein interactions.\\2013Chembiochem : a European journal of chemical biology, Feb-11, Volume: 14, Issue:3
Using a fragment-based approach to target protein-protein interactions.
AID656681Inhibition of electric eel AChE using acetylcholine iodide as substrate at 10'-4 M measured every 5 sec for 2 mins by Ellman's method2012Bioorganic & medicinal chemistry letters, Apr-15, Volume: 22, Issue:8
Prospective acetylcholinesterase inhibitory activity of indole and its analogs.
AID321284Activity at human alpha-7 nACh receptor expressed in Xenopus laevis oocyte assessed as increase in acetylcholine-induced current2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
Allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
AID428332Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
AID428336Cytotoxicity against mouse B16 cells assessed as cell viability at 20 uM after 2 days by tetrazolium reduction assay2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
AID1064675Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 9 uM after 20 mins by spectrophotometric analysis2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
AID1064674Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
AID420374Inhibition of peptidase activity of human recombinant LTA4H expressed in Escherichia coli BL21-AI/pRARE2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID428333Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation at 100 uM2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
AID1164763Positive allosteric modulation at human alpha7 nACHR expressed in Xenopus oocyte assessed as potentiation of 0.1 mM ACh-induced current at holding potential of -80 mV by electrophysiology relative to control2014European journal of medicinal chemistry, Oct-30, Volume: 86Chalcones as positive allosteric modulators of α7 nicotinic acetylcholine receptors: a new target for a privileged structure.
AID428334Inhibition of catecholase activity of tyrosinase in human HMVII cells assessed as dopachrome formation at 100 uM2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
AID420373Solubility in methanol2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID428335Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
AID420376Inhibition of ionomycin-stimulated LTB4 production in human whole blood treated 15 mins prior to ionomycin challenge measured after 30 mins of stimulation by enzyme-linked immunosorbent assay2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID1064677Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 33 uM after 20 mins by spectrophotometric analysis2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
AID420375Inhibition of hydrolase activity of human recombinant LTA4H expressed in Escherichia coli BL21-AI/pRARE assessed as LTB4 formation by tandem quadrupole mass spectrometry2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID763541Antioxidant activity assessed as inhibition of ABTS free radical generation at 9 uM after 20 mins by UV spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
AID763542Antioxidant activity assessed as inhibition of ABTS free radical generation at 17 uM after 20 mins by UV spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
AID1207141Binding affinity to RAD51 (unknown origin) by isothermal calorimetry2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Chembiochem : a European journal of chemical biology, Feb-11, Volume: 14, Issue:3
Using a fragment-based approach to target protein-protein interactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (150)

TimeframeStudies, This Drug (%)All Drugs %
pre-199065 (43.33)18.7374
1990's13 (8.67)18.2507
2000's29 (19.33)29.6817
2010's36 (24.00)24.3611
2020's7 (4.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.12 (24.57)
Research Supply Index5.07 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index51.42 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.94%)5.53%
Reviews5 (3.23%)6.00%
Case Studies1 (0.65%)4.05%
Observational0 (0.00%)0.25%
Other146 (94.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]